Tse‐Kuan Yu
About
Tse‐Kuan Yu is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology.
According to data from OpenAlex, Tse‐Kuan Yu has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 13 papers in Pathology and Forensic Medicine and 10 papers in Oncology. Recurrent topics in Tse‐Kuan Yu's work include Breast Cancer Treatment Studies (19 papers), Breast Lesions and Carcinomas (13 papers) and Advanced Radiotherapy Techniques (6 papers). Tse‐Kuan Yu is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), Breast Lesions and Carcinomas (13 papers) and Advanced Radiotherapy Techniques (6 papers). Tse‐Kuan Yu collaborates with scholars based in United States, Australia and China. Tse‐Kuan Yu's co-authors include Thomas A. Buchholz, Eric A. Strom, Wendy A. Woodward, Julia Oh, Welela Tereffe, Kelly K. Hunt, George H. Perkins, Elizabeth A. Grimm, Eva G. Caudell and Gabriel N. Hortobágyi and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.
In The Last Decade
Tse‐Kuan Yu
31 papers receiving 1.6k citations
Peers
Tse‐Kuan Yu
Deirdre Jill Cohen United States
Sing-Fai Leung Hong Kong
Joseph M. Jenrette United States
Koh‐ichi Sakata Japan
Sergio Maluta Italy
Chien-Sheng Tsai Taiwan
Y.F. Poon China
Bruce A. Bornstein United States
Makiko Itami Japan
G Juillard United States
Citations per year, relative to Tse‐Kuan Yu Tse‐Kuan Yu (= 1×)
peers
Deirdre Jill Cohen
Countries citing papers authored by Tse‐Kuan Yu
Since
Specialization
Citations
This map shows the geographic impact of Tse‐Kuan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tse‐Kuan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tse‐Kuan Yu more than expected).
Fields of papers citing papers by Tse‐Kuan Yu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Tse‐Kuan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tse‐Kuan Yu. The network helps show where Tse‐Kuan Yu may publish in the future.
Co-authorship network of co-authors of Tse‐Kuan Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Tse‐Kuan Yu. A scholar is included among the top collaborators of Tse‐Kuan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tse‐Kuan Yu. Tse‐Kuan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Caudle, Abigail S., Tse‐Kuan Yu, Susan L. Tucker, et al.. (2012). Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy. Breast Cancer Research. 14(3). R83–R83.
2.
Nagar, Himanshu, Elizabeth A. Mittendorf, Eric A. Strom, et al.. (2011). Local-Regional Recurrence With and Without Radiation Therapy After Neoadjuvant Chemotherapy and Mastectomy for Clinically Staged T3N0 Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 81(3). 782–787.
3.
Woodward, Wendy A., Pauline T. Truong, Tse‐Kuan Yu, et al.. (2010). Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival. Breast Cancer Research and Treatment. 123(2). 597–605.
4.
Costelloe, Colleen M., Eric Rohren, John E. Madewell, et al.. (2009). Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. The Lancet Oncology. 10(6). 606–614.
5.
Zhang, Yu‐Jing, Julia Oh, Gary J. Whitman, et al.. (2009). Clinically Apparent Internal Mammary Nodal Metastasis in Patients With Advanced Breast Cancer: Incidence and Local Control. International Journal of Radiation Oncology*Biology*Physics. 77(4). 1113–1119.
6.
Kumar, Karthik, Rony Avritscher, Youmin Wang, et al.. (2009). Handheld histology-equivalent sectioning laser-scanning confocal optical microscope for interventional imaging. Biomedical Microdevices. 12(2). 223–233.
7.
Zhang, Sean X., Thomas A. Buchholz, Zhong Lin Wang, et al.. (2009). Quantifying tumor-selective radiation dose enhancements using gold nanoparticles: a monte carlo simulation study. Biomedical Microdevices. 11(4). 925–933.
8.
Reed, Valerie, Eric A. Strom, George H. Perkins, et al.. (2008). Risk of Subclinical Micrometastatic Disease in the Supraclavicular Nodal Bed According to the Anatomic Distribution in Patients With Advanced Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 71(2). 435–440.
9.
Beadle, Beth M., Wendy A. Woodward, Susan L. Tucker, et al.. (2008). Ten-Year Recurrence Rates in Young Women With Breast Cancer by Locoregional Treatment Approach. International Journal of Radiation Oncology*Biology*Physics. 73(3). 734–744.
10.
Buchholz, Thomas A., Wendy A. Woodward, Zhigang Duan, et al.. (2008). Radiation Use and Long-Term Survival in Breast Cancer Patients With T1, T2 Primary Tumors and One to Three Positive Axillary Lymph Nodes. International Journal of Radiation Oncology*Biology*Physics. 71(4). 1022–1027.
11.
Yu, Tse‐Kuan, Jeremy J. Erasmus, George H. Perkins, et al.. (2007). Treatment Optimization Using Computed Tomography-Delineated Targets Should be Used for Supraclavicular Irradiation for Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 69(3). 711–715.
12.
McGuire, Sean E., Ana M. González-Angulo, Eugene Huang, et al.. (2007). Postmastectomy Radiation Improves the Outcome of Patients With Locally Advanced Breast Cancer Who Achieve a Pathologic Complete Response to Neoadjuvant Chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 68(4). 1004–1009.
13.
Oh, Julia, Gary J. Whitman, Kelly K. Hunt, et al.. (2007). Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer. 110(11). 2420–2427.
14.
Wahl, Andrew O., Alfred Rademaker, Krystyna Kiel, et al.. (2007). Multi-Institutional Review of Repeat Irradiation of Chest Wall and Breast for Recurrent Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 70(2). 477–484.
15.
Lü, Jiachun, Qingyi Wei, Melissa L. Bondy, et al.. (2007). Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged ≤55 years. Breast Cancer Research and Treatment. 110(2). 357–366.
16.
Huang, Eugene, Eric A. Strom, Vicente Valero, et al.. (2007). Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. International Journal of Radiation Oncology*Biology*Physics. 67(2). 490–496.
17.
Akyürek, Serap, Eric Chang, Tse‐Kuan Yu, et al.. (2006). Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center. Journal of Neuro-Oncology. 80(2). 177–183.
18.
Borghero, Yerko, Mohammad Salehpour, Marsha D. McNeese, et al.. (2006). Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: A phantom model comparison. Radiotherapy and Oncology. 82(3). 324–328.
19.
Yu, Tse‐Kuan, et al.. (2000). IL-2 Activation of NK Cells: Involvement of MKK1/2/ERK But Not p38 Kinase Pathway. The Journal of Immunology. 164(12). 6244–6251.
20.
Frederick, Mitchell J., et al.. (1996). Protein tyrosine kinase inhibition blocks granule exocytosis and cytolytic function of lymphokine-activated killer cells. Immunopharmacology. 35(2). 83–102.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Deirdre Jill Cohen Breakdown of academic impact, for papers by Sing-Fai Leung Breakdown of academic impact, for papers by Joseph M. Jenrette Breakdown of academic impact, for papers by Koh‐ichi Sakata Breakdown of academic impact, for papers by Sergio Maluta Breakdown of academic impact, for papers by Chien-Sheng Tsai Breakdown of academic impact, for papers by Y.F. Poon Breakdown of academic impact, for papers by Bruce A. Bornstein Breakdown of academic impact, for papers by Makiko Itami Breakdown of academic impact, for papers by G Juillard